BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 34296479)

  • 1. Stabilization of G-Quadruplex Structures of the SARS-CoV-2 Genome by TMPyP4, BRACO19, and PhenDC3.
    Cervenak M; Molnár OR; Horváth P; Smeller L
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics.
    Tao HY; Zhao CY; Wang Y; Sheng WJ; Zhen YS
    Int J Nanomedicine; 2024; 19():3805-3825. PubMed ID: 38708177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability.
    Jin T; Ding L; Chen J; Zou X; Xu T; Xuan Z; Wang S; Chen J; Wang W; Zhu C; Zhang Y; Huang P; Pan Z; Ge M
    J Cell Mol Med; 2024 Apr; 28(7):e18182. PubMed ID: 38498903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative genomic analyses of promoter G-quadruplexes reveal their selective constraint and association with gene activation.
    Li G; Su G; Wang Y; Wang W; Shi J; Li D; Sui G
    Commun Biol; 2023 Jun; 6(1):625. PubMed ID: 37301913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Localization of Selected Porphyrins and Their Effect on the In Vitro Motility of Human Colon Tumors and Normal Cells.
    Frant MP; Trytek M; Deryło K; Kutyła M; Paduch R
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between G-quadruplex and ROS.
    Wu S; Jiang L; Lei L; Fu C; Huang J; Hu Y; Dong Y; Chen J; Zeng Q
    Cell Death Dis; 2023 Jan; 14(1):37. PubMed ID: 36653351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential interplay between G-quadruplex and p53: their roles in regulation of ferroptosis in cancer.
    Zhang L; Lu Y; Ma X; Xing Y; Sun J; Jia Y
    Front Mol Biosci; 2022; 9():965924. PubMed ID: 35959461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?
    De Martino V; Rossi M; Battafarano G; Pepe J; Minisola S; Del Fattore A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different biological effects of TMPyP4 and cisplatin in the inflammatory microenvironment of osteosarcoma are attributed to G-quadruplex.
    Chen J; Jin X; Mei Y; Shen Z; Zhu J; Shi H; Wang M; Zheng X; Liang G
    Cell Prolif; 2021 Sep; 54(9):e13101. PubMed ID: 34296479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cisplatin Derivative Tetra-Pt(bpy) as an Oncotherapeutic Agent for Targeting ALT Cancer.
    Zheng XH; Nie X; Fang Y; Zhang Z; Xiao Y; Mao Z; Liu H; Ren J; Wang F; Xia L; Huang J; Zhao Y
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
    Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
    J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.
    Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Kawano T; Agawa M; Ida H; Yamada H
    Exp Eye Res; 2009 Aug; 89(2):200-8. PubMed ID: 19328784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
    Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
    Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.